143 related articles for article (PubMed ID: 7773086)
1. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
[TBL] [Abstract][Full Text] [Related]
2. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
[TBL] [Abstract][Full Text] [Related]
5. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
Zachariah PK; Messerli FH; Mroczek W
Clin Ther; 1993; 15(5):779-87. PubMed ID: 8269444
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
8. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
9. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
10. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
BLoem TJ; Lindner PC
Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
[TBL] [Abstract][Full Text] [Related]
11. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
[TBL] [Abstract][Full Text] [Related]
12. [The effect of acebutolol and metoprolol on noninvasive ambulatory blood pressure monitoring system in essential hypertension].
Kotake C; Koya Y; Ikeda S; Ikeda Y; Onaka H; Suyama K; Ichinohe T; Hayashi T; Kawaguchi K; Seo T
Kokyu To Junkan; 1992 Sep; 40(9):885-90. PubMed ID: 1439288
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
[TBL] [Abstract][Full Text] [Related]
14. Studies with a new cardioselective beta-blocker, metoprolol.
Werkö L; Aurell M; Johnsson G; Sannerstedt R; Svedmyr N
Adv Clin Pharmacol; 1976; 11():19-25. PubMed ID: 1032569
[TBL] [Abstract][Full Text] [Related]
15. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
[TBL] [Abstract][Full Text] [Related]
16. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
18. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
Soucek M; Prásek J; Spinarová L
Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
[TBL] [Abstract][Full Text] [Related]
19. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
Metelitsa VI; Filatova NP
Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
